Timmerman Traverse for Damon Runyon, Kilimanjaro 2024 Photo Gallery
The Timmerman Traverse for Damon Runyon Cancer Research Foundation is in the books.
We have raised about $1.1 million for this national network of brilliant, brave and bold young scientists.
All 20 members of the team made it to the summit of Kilimanjaro, the highest peak in Africa, at 19,341 feet.
It’s an experience none of us will ever forget.
We had some rainy days, some sunny days, and truly stellar night skies. We were lucky to have picture-perfect weather on summit day. We marveled at the changing landscape, from the forest zone, to the heather and morland, to the alpine desert at higher elevation.
Team Roster
- Luke Timmerman, founder & editor, Timmerman Report (team leader)
- Eric Murphy, lead guide, Alpine Ascents International
- Joanne Smith-Farrell, CEO, Be Biopharma
- Nagesh Mahanthappa, executive chair, Exo Therapeutics
- Erika Smith, CEO, ReNetX Bio; BIO board member
- Jaime Smith, CEO, Lodestar Energy
- Abbas Kazimi, chief business officer, Nimbus Therapeutics
- Martin Strebl-Bantillo, principal, Clarion, a Lumanity Business
- Stella Paffenholz, venture capital fellow, Nextech Invest
- Mike Huckman, global practice leader, executive communications, Real Chemistry; BIO board member
- Henry Kilgore, postdoctoral researcher, Whitehead Institute, Richard Young Laboratory; Damon Runyon Fellow
- Wei (Will) Chen, postdoctoral researcher, University of Washington, David Baker Laboratory; Damon Runyon Fellow
- Katherine Andersen, head of life sciences and healthcare, HSBC USA commercial banking
- Jason Steiner, biotech<>techbio architect
- Mairin Rooney, M&A advisor, Coruscate Group
- Dave Frakes, vice president, regional medical officer, PPD, part of Thermo Fisher Scientific
- Hari Pujar, operating partner, Flagship Pioneering
- Teri Loxam, chief financial officer, Compass Pathways
- Pablo Lubroth, investor, Hummingbird Ventures
- Yaron Werber, senior biotechnology analyst, TD Cowen
- Guang Yang, partner, McKinsey & Co.
Enjoy the photos